Sexually Transmitted Infections (STIs) Market 2025-2034: Key Highlights, Growth Dynamics, and Emerging Trends
Discover trends, market shifts, and competitive outlooks for the sexually transmitted infections (stis) industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research
What Are the Key Projections for the CAGR of the Sexually Transmitted Infections (STIs) Market Size From 2025 to 2034?
The market sector for sexually transmitted infections (STIs) has experienced a swift expansion in size over the previous years. It is projected to increase from $63.69 billion in 2024 to $71.93 billion in 2025, marking a compound annual growth rate (CAGR) of 12.9%. Factors such as behavioral patterns, education and awareness programs, access to healthcare, and the development of antibiotics have been pivotal influences on the growth experienced within the historical period.
Predictions show a swift expansion for the market of Sexually Transmitted Infections (STIs) in the coming years. By 2029, it is anticipated to reach a value of $113.38 billion, with a compound annual growth rate (CAGR) of 12.0%. Factors contributing to this growth throughout the forecast period are the development of new STI strains, vaccination campaigns, the rise of telemedicine and home testing, and sexual health equality. Key trends to watch during this period will be an increase in antimicrobial resistance, the use of pre-exposure prophylaxis (prep), self-management of STIs, and improved sexual education.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13047&type=smp
Which Primay Drivers Are Accelerating Growth in the Sexually Transmitted Infections (STIs) Market?
Increasing efforts by governments to raise public awareness about sexually transmitted infections are expected to fuel the growth of the sexually transmitted infections (STIs) market. A government initiative is a strategic tool employed to accomplish targeted objectives and to address specific issues. Several such initiatives have been put in place by governments around the globe to mitigate, manage, and treat STIs. These include providing funding for public education campaigns to increase STIs awareness, developing vaccines to ward off certain STIs, and offering free or cost-effective screening and testing services. An illustration of this is the Disease Intervention Specialist (DIS) program introduced by the US-based Springfield-Greene County Health, in conjunction with Missouri Department of Health and Senior Services, in April 2023. The program aims to tackle the escalating spread of STIs in Greene County, with its primary focus being on syphilis and HIV. Hence, the rise in government-led initiatives is anticipated to enhance the market for sexually transmitted infections (STIs). To fuel this discussion further, the growing prevalence of unsafe sex is set to stimulate the sexually transmitted infections (STIs) market. The increasing trend of unprotected sex refers to when individuals engage in sexual activities without using preventative measures like condoms, thereby paving the way for the spread of STIs. An example of this can be seen in a report by the World Health Organization in August 2024 that stated that the percentage of sexually active teenagers using condoms during their last sexual encounter had reduced in 2022. The report highlighted a decrease from 70% to 61% in boys and from 63% to 57% in girls. Thus, the escalating trend of unprotected sex will drive growth in the sexually transmitted infections (STIs) market.
Which Primary Segments of the Sexually Transmitted Infections (STIs) Market Are Driving Growth and Industry Transformations?
The sexually transmitted infections (STIs) market covered in this report is segmented –
1) By Type: Human Immunodeficiency Virus (HIV), Human Papilloma Virus (HPV), Gonorrhea, Syphilis, Other Types
2) By Treatment: Antibiotics, Antiviral
3) By Location Of Testing: Laboratory Testing, Point-Of-Care (POC) Testing
4) By Route Of Administration: Oral, Parenteral, Other Route Of Administration
5) By End-Users: Hospitals, Specialty Clinics, Homecare, Other End-Users
Subsegments:
1) By Human Immunodeficiency Virus (HIV): HIV Type 1, HIV Type 2
2) By Human Papilloma Virus (HPV): Low-Risk HPV, High-Risk HPV
3) By Gonorrhea: Uncomplicated Gonorrhea, Complicated Gonorrhea
4) By Syphilis: Primary Syphilis, Secondary Syphilis, Tertiary Syphilis
5) By Other Types: Chlamydia, Herpes Simplex Virus (HSV), Hepatitis B, Hepatitis C, Trichomoniasis
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=13047&type=smp
Which Regions Are Key Players in the Growth of the Sexually Transmitted Infections (STIs) Market?
North America was the largest region in the sexually transmitted infection (STIs) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in sexually transmitted infections (STIs) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
What Are the Most Significant Market Trends in the Sexually Transmitted Infections (STIs) Market?
Leading businesses in the sexually transmitted infections (STIs) market are leveraging fluorescent PCR (Polymerase Chain Reaction) technology by creating cutting-edge products, in order to stay competitive in the sector. This molecular biology method has the ability to identify and measure specific DNA sequences in a biological sample. For example, in March 2023, Jiangsu Bioperfectus Technologies Co. Ltd., a China-based company specializing in molecular diagnostic solutions, unveiled two new polymer chain reaction (PCR) kits – the Mycoplasma Hominis Real-Time PCR Kit and the Treponema Pallidum Real-Time PCR Kit. These kits offer a comprehensive PCR solution for early detection of STIs, affecting a large number of individuals. The BioPerfectus Mycoplasma Hominis Real-Time PCR Kit is a reagent utilizing fluorescent PCR technology to identify Mycoplasma hominis in human male urethral swabs, female cervical or vaginal swabs and urine samples. The BioPerfectus Treponema Pallidum Real-Time PCR Kit is specifically developed to locate treponema pallidum nucleic acid in human serum and plasma.
View the full report here:
What Parameters Are Used to Define the Sexually Transmitted Infections (STIs) Market?
Sexually transmitted infections (STIs), also known as sexually transmitted diseases (STDs), refer to diseases caused by viruses, bacteria and parasites that are passed from one person to another through sexual contact. These infections can be transmitted by vaginal, anal and oral sex and through skin-to-skin contact.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13047
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
